Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The march of science.

Rivara FP, Christakis DA.

Arch Pediatr Adolesc Med. 2007 Dec;161(12):1214-5. No abstract available.

PMID:
18056569
2.

Hepatitis B vaccine and risk of multiple sclerosis.

DeStefano F, Verstraeten T, Chen RT.

Expert Rev Vaccines. 2002 Dec;1(4):461-6. Review.

PMID:
12901584
3.

Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board.

Halsey NA, Duclos P, Van Damme P, Margolis H.

Pediatr Infect Dis J. 1999 Jan;18(1):23-4. Review. No abstract available.

PMID:
9951975
4.

Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.

Demicheli V, Rivetti A, Di Pietrantonj C, Clements CJ, Jefferson T.

J Viral Hepat. 2003 Sep;10(5):343-4. Review. No abstract available.

PMID:
12969184
5.

[Hepatitis B vaccine and multiple sclerosis].

Campins Martí M, Moraga Llop FA.

An Esp Pediatr. 1998 Dec;49(6):555-7. Review. Spanish. No abstract available.

PMID:
9972614
6.

[Current opinion 2004: The relationship between multiple sclerosis and hepatitis B vaccination in adults].

Gout O, Lyon-Caen O.

Rev Neurol (Paris). 2004 Dec;160(12):1147-9. Review. French. No abstract available.

PMID:
15602359
7.

[Hepatitis B vaccine and multiple sclerosis: an unproved association].

Salleras L, Bruguera M, Prat A.

Med Clin (Barc). 2006 Apr 22;126(15):581-8. Review. Spanish. No abstract available.

PMID:
16756923
8.

Hepatitis A and B immunization for individuals with inherited bleeding disorders.

Steele M, Cochrane A, Wakefield C, Stain AM, Ling S, Blanchette V, Gold R, Ford-Jones L.

Haemophilia. 2009 Mar;15(2):437-47. doi: 10.1111/j.1365-2516.2008.01954.x. Review.

PMID:
19335752
9.

[Epidemiology of multiple sclerosis: The special situation in France].

Fromont A, Binquet C, Clerc L, Moreau T.

Rev Neurol (Paris). 2009 Aug-Sep;165(8-9):671-5. doi: 10.1016/j.neurol.2009.04.003. Epub 2009 May 17. Review. French.

PMID:
19447457
10.

[The role of environmental factors in multiple sclerosis pathogenesis].

Pierzchała K, Kubicka K.

Wiad Lek. 2009;62(1):37-41. Review. Polish.

PMID:
19817256
11.

Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.

Beran J.

Expert Rev Vaccines. 2007 Dec;6(6):891-902. doi: 10.1586/14760584.6.6.891. Review.

PMID:
18377352
12.

[Diagnosis and pharmacological treatment of multiple sclerosis].

Kleiter I, Steinbrecher A.

Fortschr Neurol Psychiatr. 2007 Jun;75(6):363-71; quiz 372-4. Review. German. No abstract available.

PMID:
17549661
13.

[Advance in immunization of hepatitis B vaccine research].

Liu XE, Zhuang H.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Sep;29(9):941-4. Review. Chinese. No abstract available.

PMID:
19180731
14.

The global impact of vaccination against hepatitis B: a historical overview.

Zanetti AR, Van Damme P, Shouval D.

Vaccine. 2008 Nov 18;26(49):6266-73. doi: 10.1016/j.vaccine.2008.09.056. Epub 2008 Oct 9. Review.

PMID:
18848855
15.

Multiple sclerosis: immunopathogenesis and controversies in defining the cause.

Holmøy T, Hestvik AL.

Curr Opin Infect Dis. 2008 Jun;21(3):271-8. doi: 10.1097/QCO.0b013e3282f88b48. Review.

PMID:
18448972
16.

[Prevention of needle-stick injuries].

Kärcher E.

MMW Fortschr Med. 2008 Feb 7;150(6):33-4. Review. German. No abstract available.

PMID:
18323342
17.

Update on vaccine-preventable diseases: are adults in your community adequately protected?

Schaffner W.

J Fam Pract. 2008 Apr;57(4 Suppl):S1-11; quiz S12. Review.

PMID:
18655764
18.

Hepatitis B vaccination in travelers.

Sonder GJ.

Expert Rev Vaccines. 2008 Jul;7(5):673-7. doi: 10.1586/14760584.7.5.673. Review.

PMID:
18564021

Supplemental Content

Support Center